Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort …
…, WJE Bemelmans, RT Hoogenveen… - Archives of internal …, 2007 - jamanetwork.com
Background The extent to which moderate overweight (body mass index [BMI], 25.0-29.9 [calculated
as weight in kilograms divided by height in meters squared]) and obesity (BMI, ≥ …
as weight in kilograms divided by height in meters squared]) and obesity (BMI, ≥ …
Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
M Hoogendoorn, TL Feenstra, RT Hoogenveen… - Thorax, 2010 - thorax.bmj.com
Background The aim of this study was to estimate the long-term (cost-) effectiveness of smoking
cessation interventions for patients with chronic obstructive pulmonary disease (COPD). …
cessation interventions for patients with chronic obstructive pulmonary disease (COPD). …
Association between lung function and exacerbation frequency in patients with COPD
…, TL Feenstra, RT Hoogenveen… - … journal of chronic …, 2010 - Taylor & Francis
Purpose To quantify the relationship between severity of chronic obstructive pulmonary
disease (COPD) as expressed by Global Initiative for Chronic Obstructive Lung Disease (GOLD) …
disease (COPD) as expressed by Global Initiative for Chronic Obstructive Lung Disease (GOLD) …
[HTML][HTML] Lifetime medical costs of obesity: prevention no cure for increasing health expenditure
Background Obesity is a major cause of morbidity and mortality and is associated with high
medical expenditures. It has been suggested that obesity prevention could result in cost …
medical expenditures. It has been suggested that obesity prevention could result in cost …
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands
…, MLL van GENUGTEN, RT Hoogenveen… - American journal of …, 2001 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) causes extensive disability, primarily among
the elderly. On the World Health Organization ranking list of disability-adjusted life years (…
the elderly. On the World Health Organization ranking list of disability-adjusted life years (…
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach
M Hoogendoorn, RT Hoogenveen… - European respiratory …, 2011 - Eur Respiratory Soc
The aim of our study was to estimate the case fatality of a severe exacerbation from long-term
survival data presented in the literature. A literature search identified studies reporting ≥…
survival data presented in the literature. A literature search identified studies reporting ≥…
Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study
…, HH Hamberg-van Reenen, RT Hoogenveen… - Value in Health, 2005 - Elsevier
OBJECTIVES: To estimate the cost-effectiveness of five face-to-face smoking cessation
interventions (ie, minimal counseling by a general practitioner (GP) with, or without nicotine …
interventions (ie, minimal counseling by a general practitioner (GP) with, or without nicotine …
Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study
…, G Bos, WJ Bemelmans, RT Hoogenveen… - Diabetes …, 2007 - Am Diabetes Assoc
OBJECTIVE—In the current study we explore the long-term health benefits and cost-effectiveness
of both a community-based lifestyle program for the general population (community …
of both a community-based lifestyle program for the general population (community …
Cost-effectiveness of lifestyle modification in diabetic patients
…, PH van Baal, RT Hoogenveen… - Diabetes …, 2009 - Am Diabetes Assoc
OBJECTIVE To explore the potential long-term health and economic consequences of
lifestyle interventions for diabetic patients. RESEARCH DESIGN AND METHODS A literature …
lifestyle interventions for diabetic patients. RESEARCH DESIGN AND METHODS A literature …
[HTML][HTML] Projecting the COPD population and costs in England and Scotland: 2011 to 2030
S McLean, M Hoogendoorn, RT Hoogenveen… - Scientific reports, 2016 - nature.com
We aimed to estimate the prevalence, healthcare costs and number of deaths among
people with chronic obstructive pulmonary disease (COPD) in England and Scotland 2011–2030. …
people with chronic obstructive pulmonary disease (COPD) in England and Scotland 2011–2030. …